GCC Pharmaceutical Market Sales Size Report 2025

GCC Pharmaceutical Market Sales Size Report 2025

According to "GCC Pharmaceutical Market Opportunity Insight 2025" Report, the pharmaceutical market opportunity in GCC is expected to surpass US$ 20 Billion by 2025. The GCC pharma market has been witnessing exponential growth driven by high demand of branded and patented drugs.

"GCC Pharmaceutical Market Opportunity Insight 2025" Report Highlights:

o GCC Pharmaceutical Market Opportunity: > US$ 20 Billion
o Patented & OTC Pharmaceutical Market Size: 75% of Total Market
o Share of Imported Drugs In GCC Pharmaceutical Market: > 80%
o Saudi Arabia Dominates GCC Pharmaceutical Market: 50% Market Share
o GCC Pharmaceutical Clinical Trials Insight: > 700 Drugs

Download Report: https://www.kuickresearch.com/report-gcc-pharmaceutical-market-opportunity-insight-2025.php

Table of Contents

1. Introduction to Gulf Cooperation Council (GCC) Pharmaceutical Market

1.1 Overview
1.2 GCC Pharmaceutical Market Analysis

2. GCC Pharmaceutical Market by Indication - Prevalence & Statistics

2.1 Cancer
2.1.1 Overview
2.1.2 Prevalence by Cancer Type & Gender
2.1.3 Cancer Prevalence & Statistics by GCC Countries
2.2 Diabetes
2.3 HIV/AIDS
2.4 Cardiovascular Diseases
2.4.1 Coronary Heart Disease
2.4.2 Hypertension
2.4.3 Stroke
2.5 Obesity
2.6 Respiratory Disorders
2.6.1 Asthma
2.6.2 Tuberculosis
2.6.3 Influenza & Pneumonia
2.6.4 Other Respiratory Diseases - COPD & Cystic Fibrosis
2.7 Alzheimer's Disease/Dementia

3. GCC - Regulatory Aspects of Pharmaceuticals

3.1 Gulf Central Committee for Drug Registrations (GCC-DR)
3.2 Regulatory Review Process
3.3 Centralized Registration
3.4 Decentralized Drug Registration Regulation
3.4.1 Saudi Arabia
3.4.2 Kuwait
3.4.3 UAE
3.4.4 Bahrain
3.4.5 Qatar
3.4.6 Oman
3.5 Gulf Joint Procurement Program

4. GCC - Pharmaceutical Pricing & Reimbursement Policies

4.1 Pricing Policies
4.1.1 In-Patent Pharmaceuticals
4.1.2 Off-Patent & Generic Pharmaceuticals
4.1.3 Locally & Multinational Manufactured Pharmaceuticals
4.2 Procurement & Reimbursement Policies
4.2.1 In-Patent Pharmaceuticals
4.2.2 Off-Patent, Generics & Biosimilars

5. GCC Pharmaceutical Market by Product

5.1Generics Pharmaceuticals
5.2 Patented & OTC Pharmaceuticals
5.3 Biosimilars

6. Saudi Arabia Pharmaceutical Market Analysis

6.1 Overview
6.2 Saudi Arabia Pharmaceutical Market by Products
6.3 Saudi Arabia Pharmaceutical Market by Companies
6.4 Saudi Arabia Pharmaceutical Market by Type

7. UAE Pharmaceutical Market Analysis

7.1 Overview
7.2 UAE Pharmaceuticals Market by Product
7.3 UAE Pharmaceutical Market by Companies
7.4 UAE Pharmaceutical Market by Type

8. Kuwait Pharmaceutical Market Analysis

8.1 Overview
8.2 Kuwait Pharmaceutical Market by Therapeutic Indication & Products
8.3 Kuwait Pharmaceutical Market by Companies
8.4 Kuwait Pharmaceutical Market by Type

9. Bahrain Pharmaceutical Market Analysis

9.1 Overview
9.2 Bahrain Pharmaceutical Market by Products
9.3 Bahrain Pharmaceutical market by Companies
9.4 Bahrain Pharmaceutical Market by Product Type

10. Qatar Pharmaceutical Market Analysis

10.1 Overview
10.2 Qatar Pharmaceutical Market by Type

11. Oman Pharmaceutical Market Analysis

11.1 Overview
11.2 Oman Pharmaceutical Market by Product Type

12. GCC Pharmaceutical Market - International Trade

12.1 Import Market
12.2 Pharmaceutical Export Market

13. GCC Pharmaceutical Market - Clinical Trials Insight

13.1 Overview
13.2 Clinical Trials by Indication
13.2.1 Cancer
13.2.2 Diabetes
13.2.3 CVS Disorders
13.2.4 Respiratory Disorders
13.3 Clinical Insight by GCC Countries
13.3.1 Saudi Arabia
13.3.2 United Arab Emirates
13.3.3 Kuwait
13.3.4 Bahrain
13.3.5 Qatar
13.3.6 Oman

14. GCC Pharmaceutical Market Drivers

15. Challenges for GCC Pharmaceutical Market

16. GCC Pharmaceutical Market Future Outlook - Trends & Opportunities

17. Competitive Landscape

17.1 Local Pharmaceutical Companies
17.1.1 Julphur Pharmaceuticals
17.1.2 SPIMACO Addwaeih
17.1.3 Qatar Life Pharma
17.1.4 Al Mojil Drug Company
17.1.5 Kuwait Saudi Pharmaceutical Company
17.1.6 YIACO Medical Company
17.1.7 Qatar Pharma
17.1.8 Saja Pharmaceuticals
17.1.9 Oman Pharmaceuticals
17.1.10 Taiba Pharmaceuticals
17.1.11 Gulf Biotech
17.1.12 Bahrain Pharma
17.1.13 Neopharma
17.1.14 Planet Pharmacies
17.1.15 Aljazeera Pharmaceutical Industries
17.1.16 Dallah Pharma
17.1.17 Tabuk Pharmaceuticals
17.1.18 CAD Middle-East Pharmaceutical Company
17.1.19 ACDIMA
17.1.20 AL-Mufid Pharmaceuticals

17.2 Multinational Companies
17.2.1 Novartis
17.2.2 Amgen
17.2.3 Eli - Lilly
17.2.4 Merck
17.2.5 Pfizer
17.2.6 GlaxoSmithKline plc
17.2.7 Roche
17.2.8 Takeda Pharmaceuticals
17.2.9 Teva Pharmaceuticals
17.2.10 AstraZeneca plc
17.2.11 Genentech
17.2.12 Sanofi

Contact:
Neeraj Chawla
neeraj@kuickresearch.com
+91-11-47067990

Delhi;India, Tel; +91-11-47067990

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

This release was published on openPR.